Skip to main content

Table 3 Serology of 1091 DUs by gender

From: Patients in long-term maintenance therapy for drug use in Italy: analysis of some parameters of social integration and serological status for infectious diseases in a cohort of 1091 patients

  

No. of subjects (%)

Serology

Female*

Male*

Total*

p*

HIV

Negative

138 (80.7)

761 (82.7)

899 (82.4)

0.040

 

Positive

29 (17.0)

107 (11.6)

136 (12.5)

 
 

Unknown

4 (2.3)

52 (5.6)

56 (5.1)

 

HBV

Negative

47 (27.5)

195 (21.2)

242 (22.1)

0.096

 

Positive

76 (44.4)

385 (41.8)

461 (42.2)

 
 

Unknown

6 (3.5)

55 (6.0)

61 (6.0)

 
 

Vaccinated

42 (24.6)

285 (31.0)

327 (30.0)

 

HCV

Negative

33 (19.3)

209 (22.7)

242 (22.2)

0.806

 

Positive

127 (74.3)

657 (71.4)

784 (71.9)

 
 

Unknown

11 (6.4)

54 (5.9)

65 (6.0)

 

TPHA

Negative

128 (74.9)

679 (73.8)

807 (74.0)

0.060

 

Positive

6 (3.5)

11 (1.2)

17 (1.5)

 
 

Unknown

37 (21.6)

230 (25.0)

267 (24.5)

 
  1. Percentages by column; *p-value of the chi-square test for association.